BioPharmSignal logoBioPharmSignal

Company Profile

ClearPoint Neuro Stock Price, News & Catalysts

Ticker:
CLPT
Exchange:
NASDAQ
Sector:
Biopharma
Location:
United States

Stock performance

15.50 USD (+1.04%)

Close

Last updated: August 17, 2026

371M USD

Market cap

Why the stock is moving

As of Aug 17, 2026, CLPT closed up 1.04% at $15.50. No new same-company headline was identified in the current news window.

Company overview

Brain and Spine Navigation Company

ClearPoint Neuro provides devices and services for precise navigation and therapy delivery to the brain and spine.

ClearPoint Navigation

The company’s MRI-guided platform supports stereotactic procedures including biopsy, laser ablation, deep-brain interventions, and targeted delivery of biologics.

Cell and Gene Therapy Enablement

ClearPoint works with biopharmaceutical partners on preclinical and clinical delivery of cell and gene therapies directly into the central nervous system.

Neurocritical Care Expansion

The acquisition of IRRAS added the IRRAflow active fluid-exchange system, extending the portfolio into management of intracranial bleeding and neurocritical care.

Future catalysts

    Recent news

    1. 01

      ClearPoint Neuro Reports Second Quarter 2026 Results

    2. 02

      ClearPoint Neuro Congratulates Partner Aspen Neuroscience on FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel

    3. 03

      ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026

    4. 04

      ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint

    5. 05

      ClearPoint Neuro Reports First Quarter 2026 Results

    Similar stocks

    Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

    MRIC

    ClearPoint Neuro

    INBS

    Intelligent Bio Solutions

    UTRS

    Minerva Surgical

    NDRA

    Endra

    DCTH

    Delcath Systems

    MYO

    Myomo

    MNKD

    MannKind

    OM

    Outset Medical

    Frequently Asked Questions

    What is the current stock price of ClearPoint Neuro (CLPT)?

    ClearPoint Neuro (CLPT) most recently closed at 15.50 USD, a +1.04% move versus the previous session.

    What is the market cap of ClearPoint Neuro (CLPT)?

    ClearPoint Neuro currently has a market capitalization of 371M USD on BioPharmSignal.

    What does ClearPoint Neuro do?

    Brain and Spine Navigation Company ClearPoint Neuro provides devices and services for precise navigation and therapy delivery to the brain and spine. ClearPoint Navigation The company’s MRI-guided platform supports stereotactic procedures including biopsy, laser ablation, deep-brain interventions, and targeted delivery of biologics. Cell and Gene Therapy...

    On which exchange is CLPT stock listed?

    ClearPoint Neuro (CLPT) is associated with NASDAQ, United States, Biopharma.

    What is Brain?

    Brain and Spine Navigation Company ClearPoint Neuro provides devices and services for precise navigation and therapy delivery to the brain and spine.

    Which conditions is ClearPoint Neuro targeting with Brain?

    Brain and Spine Navigation Company ClearPoint Neuro provides devices and services for precise navigation and therapy delivery to the brain and spine. ClearPoint Navigation The company’s MRI-guided platform supports stereotactic procedures including biopsy, laser ablation, deep-brain interventions, and targeted delivery of biologics. Cell and Gene Therapy...

    What is Spine?

    Brain and Spine Navigation Company ClearPoint Neuro provides devices and services for precise navigation and therapy delivery to the brain and spine.

    What is Navigation?

    Brain and Spine Navigation Company ClearPoint Neuro provides devices and services for precise navigation and therapy delivery to the brain and spine.